SONN
USDSonnet BioTherapeutics Holdings Inc. Common Stock
$3.200-0.840 (-20.792%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$4.040
High
$4.070
Low
$3.120
Volume
1.46M
Company Fundamentals
Market Cap
21.8M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.90M
Exchange
NCM
Currency
USD
52-Week Range
Low $1.08Current $3.200High $19.3
Related News
GlobeNewswire
Sonnet to Present at the MedInvest Biotech & Pharma Conference
PRINCETON, N.J., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing immunotherapeutic drugs targeted
View more
PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HBI, BFIN, PBBK, SONN on Behalf of Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.